CRISPR-Cas9: a referral decided by the OPECST

On March 4, the Parliamentary Office for Scientific and Technological Assessment (OPECST) announced adopting a feasibility study carried out by Senator Catherine Procaccia and Deputy Jean-Yves Le Déaut for a report on “the economic, environmental, health and ethical issues for biotechnology in the light of new lines of research.

The framework for the #CRISPR-Cas9 technology will be examined.

For Alliance VITA, this subject is of major importance, and the decision of the OPECST to examine this issue is encouraging.

This is a prodigious genetic engineering technique, and although future perspectives are promising, it raises ethical issues for which, France, as the country of Human Rights with its bioethical laws, has expertise to share with the rest of the world.

For more details: Expert’s note CRISPR-CAS9: the modification of the human genome

1Parliamentary Office for Scientific and Technological Assessment